Characterization of Clinical Phenotypes of Laryngeal Dystonia and Voice Tremor
Learn more about:
Related Clinical Trial
Cortical Silent Period From Cricothyroid Muscle in Laryngeal Dystonia Patients and Control Subjects
Understanding Disorder-specific Neural Pathophysiology in Laryngeal Dystonia and Voice Tremor
DaxibotulinumtoxinA Injection for Treatment of Adductor Spasmodic Dysphonia
Assessment of Laryngopharyngeal Sensation in Adductor Spasmodic Dysphonia
Deep Brain Stimulation in Laryngeal Dystonia and Voice Tremor
Characterization of Clinical Phenotypes of Laryngeal Dystonia and Voice Tremor
A Phase 2 Trial of Deep Brain Stimulation for Spasmodic Dysphonia
Spasmodic Dysphonia Pain
Laryngeal Vibration for Spasmodic Dysphonia
Sodium Oxybate in Spasmodic Dysphonia and Voice Tremor
Neuropathology of Spasmodic Dysphonia
Voice Tremor in Spasmodic Dysphonia: Central Mechanisms and Treatment Response
Study of Air Stream in Voice Production
Characteristics of Idiopathic Familial Voice Disorders
Sensory Function in Idiopathic Voice Disorders
Brain Networks in Dystonia
Imaging Genetics of Spasmodic Dysphonia
Role of Neurotransmission and Functional CNS Networks in Spasmodic Dysphonia
rTMS in Spasmodic Dysphonia
Examining the Spasmodic Dysphonia Diagnosis and Assessment Procedure (SD-DAP) for Measuring Symptom Change
Thalamic Deep Brain Stimulation for Spasmodic Dysphonia- DEBUSSY Trial
Effect of Vocal Exercise After Botulinum Toxin Injection for Spasmodic Dysphonia